Quest Partners LLC Atri Cure, Inc. Transaction History
Quest Partners LLC
- $737 Billion
- Q2 2024
A detailed history of Quest Partners LLC transactions in Atri Cure, Inc. stock. As of the latest transaction made, Quest Partners LLC holds 5,868 shares of ATRC stock, worth $162,132. This represents 0.02% of its overall portfolio holdings.
Number of Shares
5,868
Previous 4,242
38.33%
Holding current value
$162,132
Previous $129 Million
3.54%
% of portfolio
0.02%
Previous 0.02%
Shares
3 transactions
Others Institutions Holding ATRC
# of Institutions
210Shares Held
49.4MCall Options Held
111KPut Options Held
23.8K-
Vanguard Group Inc Valley Forge, PA4.62MShares$128 Million0.0% of portfolio
-
Black Rock Inc. New York, NY4.62MShares$128 Million0.0% of portfolio
-
Alliancebernstein L.P. New York, NY4.2MShares$116 Million0.03% of portfolio
-
Champlain Investment Partners, LLC Burlington, VT2.67MShares$73.9 Million0.39% of portfolio
-
Macquarie Group LTD Australia, C32MShares$55.2 Million0.05% of portfolio
About AtriCure, Inc.
- Ticker ATRC
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 46,424,700
- Market Cap $1.28B
- Description
- AtriCure, Inc. develops, manufactures, and sells devices for the surgical ablation of cardiac tissue and systems, and intercostal nerves to medical centers in the United States, Europe, Asia, and internationally. The company offers Isolator Synergy Clamps, a single-use disposable radio frequency products; multifunctional pens and linear ablation...